“It’s everywhere”. In one sentence, OUTBREAK co-founder and managing director A/Prof Branwen Morgan highlighted a key reason that tackling antimicrobial resistance (AMR) is so complex. Joining Caroline Duell, Andrew Bowskill and OUTBREAK’s Prof Antoine van Oijen for...
One of the world’s most common infections will cost Australia more than $1 billion a year within the next decade, if nothing is done to stop the rise of antibiotic resistant bacteria (superbugs). Analysis by national consortium, OUTBREAK, highlights how urinary tract...
Australian researchers are calling for more investment in finding out when, where and how current antibiotic treatments are working, as drug-resistant bacteria (superbugs) continue to spread globally. With governments and industry uniting to incentivise the...
The OUTBREAK consortium has adopted a high-performance, highly-flexible approach to turning masses of data into useful products and services to address drug-resistant infections. It’s a new way of working for a multi-agency team that’s on the hunt for information to...
A big hurdle in the fight against antimicrobial resistance (AMR) is helping Australians to understand how extensive the problem is for the whole population, not just sick people. University of Wollongong molecular microbiologist Associate Professor Martina...
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.Ok
